Deep Track Capital, LP - May 9, 2025 SCHEDULE 13G Report for Apellis Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (APLS)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Apellis Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
APLS
Shares outstanding
126M shares
Disclosed Ownership
7M shares
Ownership
5.57%
Form type
SCHEDULE 13G
Date filed
5/16/2025, 04:42 PM
Date of event
May 9, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.57% 7M 0 7M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.57% 7M 0 7M /s/ David Kroin David Kroin, Director
David Kroin 5.57% 7M 0 7M /s/ David Kroin David Kroin